Methods for treating conditions associated with MASP-2 dependent complement activation
US11981749B2 · kind B2 · utility
0Cited by
28References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 4, 2020 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Nov 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, the invention provides methods of inhibiting the effects of MASP-2-dependent complement activation in a human subject suffering from TMA associated with hematopoietic stem cell transplant. The methods comprise the step of administering, to a subject in need thereof, an amount of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.